The Wall Street Journal: The White House releases its plan to lower prescription drug prices


A Biden administration plan to lower prescription drug prices offers the first detailed road map of administrative actions the White House would support in addition to legislation aimed at driving down costs.

The plan, to be released Thursday, backs legislation from congressional Democrats, including a push to empower the federal government to negotiate for drug prices in Medicare and pass those lower costs along to the private sector. The road map goes further, however, by outlining administrative actions by agencies and departments that could come in concert with possible legislative changes.

Administrative measures include testing reimbursement for drugs in Medicare based on the clinical value they provide to patients and offering federal funding for research into new treatments, according to the plan viewed by The Wall Street Journal.

Medicare is the health program for people aged 65 and older and younger people with disabilities.

An expanded version of this story appears on

Popular stories from

: Mortgage rates remain near record lows — here’s what that means for the housing market

Previous article

Market Extra: ‘The lady isn’t tapering,’ says Lagarde as ECB slows asset purchases

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News